IPS announces the continued expansion of the EMEA region with the opening of a new office located in Dublin, Ireland.
IPS’ Ireland operations, under the leadership of Executive Director Mr. William McNamara, will offer the full array of EPCMV services to the pharmaceutical, biotechnology, and medical devices industries. In addition to providing services to the projects within Ireland, this office will also support our European operations by providing services to other European countries.
With the rapid growth in EMEA operations, IPS continues with the next phase of the region’s expansion. Ireland has a mature biotechnology and pharmaceutical industry with a strong presence of the leading companies, many of which are currently IPS’ global clients. Ireland boasts a strong, industry-specific talent pool that IPS will use to serve our global footprint. The Ireland location will work in tandem with the Switzerland office and the EMEA headquarters in Birmingham, UK, to serve clients in the EMEA region.
“This is a strategic location for our continued growth in the EMEA region,” said Dave Goswami, P.E., IPS Chairman and Chief Executive Officer, “With our new Ireland operations, we can serve the growing number of projects and opportunities in the EMEA region. We will be able to utilize the strong pharmaceutical and biotechnology base in Ireland and use the exceptionally skilled work-force in this country to serve our clients throughout the EMEA region.”
To read more go to http://ipsdb.com/pdfs/IPS_Expands_in_EMEA_Region_With_New_Ireland_Office.pdf